Maa: Valko-Venäjä
Kieli: venäjä
Lähde: Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)
Boston Scientific Corporation, СОЕДИНЕННЫЕ ШТАТЫ АМЕРИКИ
изделия медицинского назначения
Boston Scientific Corporation
2016-11-01
INSTRUCCIONES DE USO 10 MODE D’EMPLOI 19 GEBRAUCHSANWEISUNG 29 ISTRUZIONI PER L’USO 39 GEBRUIKSAANWIJZING 48 INSTRUÇÕES DE UTILIZAÇÃO 57 Boston Scientific (Master Brand DFU Template 8in x 8in Global, 90106041AK), DFU, MB, Carotid WALLSTENT, Global, 90965510-01A DIRECTIONS FOR USE 2 CAROTID WALLSTENT ™ Closed Cell Self-Expanding Stent m o n o r a i l ™ E n d o p r o s t h E s i s 2 Boston Scientific (Master Brand DFU Template 8in x 8in Global, 90106041AK), DFU, MB, Carotid WALLSTENT, Global, 90965510-01A WARNING ............................................................................................................................3 1. DEVICE DESCRIPTION ..................................................................................................3 Figure 1. Carotid WALLSTENT™ Monorail™ Endoprosthesis ...........................3 Table 1. Carotid WALLSTENT Monorail Endoprosthesis (0.014 in / 0.36 mm Guidewire Lumen) Stent Sizes and Sizing ...........................3 1.1 Contents ...................................................................................................................4 2. INTENDED USE/INDICATIONS FOR USE ...................................................................4 3. CONTRAINDICATIONS..................................................................................................4 4. WARNINGS .....................................................................................................................4 4.1 General Warnings ....................................................................................................4 4.2 Patient Selection ......................................................................................................4 4.2.1 Patient Characteristics ........................................................................................4 4.2.2 Lesion Characteristics .........................................................................................4 4.2.3 Access Characteristics ........................................ Lue koko asiakirja